Abstract

Human coronavirus OC43 is a globally circulating common cold virus sustained by recurrent reinfections. How it persists in the population and defies existing herd immunity is unknown. Here we focus on viral glycoprotein S, the target for neutralizing antibodies, and provide an in-depth analysis of its antigenic structure. Neutralizing antibodies are directed to the sialoglycan-receptor binding site in S1A domain, but, remarkably, also to S1B. The latter block infection yet do not prevent sialoglycan binding. While two distinct neutralizing S1B epitopes are readily accessible in the prefusion S trimer, other sites are occluded such that their accessibility must be subject to conformational changes in S during cell-entry. While non-neutralizing antibodies were broadly reactive against a collection of natural OC43 variants, neutralizing antibodies generally displayed restricted binding breadth. Our data provide a structure-based understanding of protective immunity and adaptive evolution for this endemic coronavirus which emerged in humans long before SARS-CoV-2.

Human coronavirus OC43 causes respiratory disease and is maintained in the human population through recurring infections. Here, by extensive structural analyses, the authors provide insights into the binding sites and breadth of neutralizing antibodies against this endemic coronavirus.

Details

Title
Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes
Author
Wang, Chunyan 1 ; Hesketh, Emma L 2   VIAFID ORCID Logo  ; Shamorkina, Tatiana M 3 ; Li, Wentao 4 ; Franken, Peter J 1 ; Drabek Dubravka 5   VIAFID ORCID Logo  ; van Haperen Rien 5 ; Townend, Sarah 2 ; van Kuppeveld Frank J M 1   VIAFID ORCID Logo  ; Grosveld, Frank 5   VIAFID ORCID Logo  ; Ranson, Neil A 2   VIAFID ORCID Logo  ; Snijder Joost 3   VIAFID ORCID Logo  ; de Groot Raoul J 1   VIAFID ORCID Logo  ; Hurdiss, Daniel L 1   VIAFID ORCID Logo  ; Bosch Berend-Jan 1   VIAFID ORCID Logo 

 Utrecht University, Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
 University of Leeds, Astbury Centre Structural Molecular Biology, School Molecular and Cellular Biology, Faculty Biological Sciences, Leeds, UK (GRID:grid.9909.9) (ISNI:0000 0004 1936 8403) 
 Utrecht University, Biomolecular Mass Spectrometry & Proteomics, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
 Utrecht University, Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234); Huazhong Agricultural University, State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Wuhan, P.R. China (GRID:grid.35155.37) (ISNI:0000 0004 1790 4137) 
 Erasmus Medical Center, Department of Cell Biology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); Harbour BioMed, Rotterdam, The Netherlands (GRID:grid.510952.a) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2669223637
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.